Health TrialsbyHealthPanel

Agitation Associated With Alzheimer's Disease Dementia

2

Review clinical trials related to Agitation Associated With Alzheimer's Disease Dementia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

To evaluate the efficacy and safety of ONO-2020 in patients with agitation associated with Alzheimer's Disease dementia in Japan.

Participants needed: 90
Trial details
Phase: Phase 2Age: 55-90Biological sex: AllType: InterventionalSponsor: Ono Pharmaceutical Co., Ltd.Updated: Sep 25, 2026Locations: 39
Eligibility criteria

Diagnosis of probable AD according to the diagnostic criteria for AD dementia (N... [+4]

Diagnosis of dementia not due to AD or any other disorder with memory impairment... [+4]

Read more
Status: Recruiting

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.

Participants needed: 300
Trial details
Phase: Phase 2, Phase 3Age: 55-90Biological sex: AllType: InterventionalSponsor: Exciva GmbHUpdated: Aug 14, 2026Locations: 49
Eligibility criteria

The participant is an adult male or female between the ages of 55 to 90 years in... [+4]

The participant has a confirmed primary diagnosis of a dementia-related disease... [+3]

Read more